AGILENT TECHNOLOGIES, INC.

Agilent Technologies Q2 FY26 — Strong Revenue Growth and Margin Expansion Driven by Ignite System

• Strength Revenue of $1.83 billion, growing 6.3% on a core basis, exceeding guidance by 80 basis points.
• Watch China revenue declined 9% in the quarter, more than expected, due to Lunar New Year timing and prior-year stocking.

Agilent Q1 FY26 — Solid Start with Strong Pharma and CAM Growth, Despite Weather Impact

• Strength Q1 revenue of $1.8 billion, growing 4.4% on a core basis, within guidance range.
• Watch Q1 revenue impacted by $10 million due to U.S. winter storm.

Agilent Q4 FY25 — Strong Core Growth Driven by LC/MS and CDMO Performance

• Strength Q4 revenue of $1.86 billion, growing 7.2% on a core basis, exceeded the high end of guidance.
• Watch China revenue declined 4% in Q4, falling below the company's low single-digit growth expectations.

Agilent Q3 FY25 — Strong Revenue Growth and Raised Full-Year Outlook

• Strength Q3 revenue of $1.74 billion exceeded guidance.
• Watch Gross margins were down year-on-year, driven by currency, tariffs, and the impact of a BIOVECTRA shutdown.

Agilent Q2 FY25 — Strong Revenue and EPS Exceed Expectations, Driven by Broad-Based Growth and Ignite Transformation

• Strength Revenue of $1.67 billion, up 5.3% core, exceeded expectations.
• Watch Operating margin was impacted by 55 basis points of incremental tariff costs.

Agilent Q1 FY25 — Strong Start Exceeding Expectations with Infinity III Momentum and China Stimulus Wins

• Strength Q1 revenue of $1.681 billion exceeded expectations.
• Watch Currency had a negative impact of 1.4 percentage points on Q1 revenue, 1 percentage point higher than estimated.